A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter

被引:156
作者
Brès, V
Kiernan, RE
Linares, LK
Chable-Bessia, C
Plechakova, O
Tréand, C
Emiliani, S
Peloponese, JM
Jeang, KT
Coux, O
Scheffner, M
Benkirane, M [1 ]
机构
[1] Inst Human Genet, Mol Virol Lab, CNRS, UPR 1142, Montpellier, France
[2] Univ Cologne, Zentrum Biochem, D-50931 Cologne, Germany
[3] Ctr Rech Biochim Macromol, UPR 1086, Montpellier, France
[4] Inst Cochin Genet Mol, Dept Malad Infect, F-75014 Paris, France
[5] NIAID, Mol Virol Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1038/ncb1023
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The human immunodeficiency virus type 1 (HIV-1) encodes a potent transactivator, Tat, which functions through binding to a short leader RNA, called transactivation responsive element (TAR). Recent studies suggest that Tat activates the HIV-1 long terminal repeat (LTR), mainly by adapting co-activator complexes, such as p300, PCAF and the positive transcription elongation factor P-TEFb, to the promoter. Here, we show that the proto-oncoprotein Hdm2 interacts with Tat and mediates its ubiquitination in vitro and in vivo. In addition, Hdm2 is a positive regulator of Tat-mediated transactivation, indicating that the transcriptional properties of Tat are stimulated by ubiquitination. Fusion of ubiquitin to Tat bypasses the requirement of Hdm2 for efficient transactivation, supporting the notion that ubiquitin has a non-proteolytic function in Tat-mediated transactivation.
引用
收藏
页码:754 / 761
页数:8
相关论文
共 32 条
  • [1] Activation of integrated provirus requires histone acetyltransferase - p300 AND P/CAF are coactivators for HIV-1 Tat
    Benkirane, M
    Chun, RF
    Xiao, H
    Ogryzko, VV
    Howard, BH
    Nakatani, Y
    Jeang, KT
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (38) : 24898 - 24905
  • [2] Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF
    Brès, V
    Tagami, H
    Péloponèse, JM
    Loret, E
    Jeang, KT
    Nakatani, Y
    Emiliani, S
    Benkirane, M
    Kiernan, RE
    [J]. EMBO JOURNAL, 2002, 21 (24) : 6811 - 6819
  • [3] FUSION FROM WITHOUT DIRECTED BY HUMAN-IMMUNODEFICIENCY-VIRUS PARTICLES
    CLAVEL, F
    CHARNEAU, P
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (02) : 1179 - 1185
  • [4] Gene expression - Emerging roles of ubiquitin in transcription regulation
    Conaway, RC
    Brower, CS
    Conaway, JW
    [J]. SCIENCE, 2002, 296 (5571) : 1254 - 1258
  • [5] MDM2: life without p53
    Daujat, S
    Neel, H
    Piette, J
    [J]. TRENDS IN GENETICS, 2001, 17 (08) : 459 - 464
  • [6] Identification, purification, and characterization of a PA700-dependent activator of the proteasome
    DeMartino, GN
    Proske, RJ
    Moomaw, CR
    Strong, AA
    Song, XL
    Hisamatsu, H
    Tanaka, K
    Slaughter, CA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (06) : 3112 - 3118
  • [7] The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II
    Ferdous, A
    Gonzalez, F
    Sun, LP
    Kodadek, T
    Johnston, SA
    [J]. MOLECULAR CELL, 2001, 7 (05) : 981 - 991
  • [8] A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3
    Glickman, MH
    Rubin, DM
    Coux, O
    Wefes, I
    Pfeifer, G
    Cjeka, Z
    Baumeister, W
    Fried, VA
    Finley, D
    [J]. CELL, 1998, 94 (05) : 615 - 623
  • [9] Recruitment of a 19S proteasome subcomplex to an activated promoter
    Gonzalez, F
    Delahodde, A
    Kodadek, T
    Johnston, SA
    [J]. SCIENCE, 2002, 296 (5567) : 548 - 550
  • [10] MDM2 induces NF-κB/p65 expression transcriptionally through Sp1-binding sites:: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia
    Gu, LB
    Findley, HW
    Zhou, MX
    [J]. BLOOD, 2002, 99 (09) : 3367 - 3375